Create a narrative

Codexis Community

NasdaqGS:CDXS Community

1 Narratives written by author
0 Comments on narratives written by author
7 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

Consensus Narrative from 6 Analysts

ECO Synthesis Launch In 2025 Will Unlock Pharma Contracts

Key Takeaways Transitioning to commercial execution with ECO Synthesis and partnerships enhances revenue growth by securing new contracts and expanding into pharma and biotech segments. GMP production and collaborations with siRNA drug innovators drive long-term profitability, supporting future large-scale manufacturing and revenue sustainability.

US$7.33

FV

64.0% undervalued

23.11%

Revenue growth p.a.

0

0

6

12 days ago